Alecsanndra L. Gonzales , Cheng-Yang Hsieh , Ureah Thea A. Sevilla , Po-Wei Tsai
{"title":"月牙草中黄酮类化合物的硅分析及其抗病毒应用前景","authors":"Alecsanndra L. Gonzales , Cheng-Yang Hsieh , Ureah Thea A. Sevilla , Po-Wei Tsai","doi":"10.1016/j.hermed.2024.100983","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Viruses, including the novel coronavirus responsible for the COVID-19 pandemic, continuously infect humans, causing illnesses of varying severity. Despite this, only a number of medicines were developed to counter some of these viruses and only preventive measures are being taken globally for some. This study explores the antiviral potential of flavonoids from <em>Crescentia cujete</em>.</div></div><div><h3>Methods</h3><div>Molecular docking was performed on seven flavonoid compounds isolated from <em>Crescentia cujete</em>, targeting viral proteins associated with COVID-19 (Omicron and Delta variants), dengue, hepatitis C, Japanese encephalitis, and influenza A. The binding affinities of these compounds were calculated to determine the most effective antiviral interactions.</div></div><div><h3>Results</h3><div>Docking simulations and absorption, distribution, metabolism, excretion, toxicity (ADMET) analyses identified naringenin as exhibiting the highest binding affinities against dengue (−10.44 kcal/mol) and COVID-19 (−9.24 and −10.31 kcal/mol) Omicron and Delta variants. Luteolin demonstrated strong activity against Hepatitis C (−10.26 kcal/mol) and Influenza A (−8.4 kcal/mol), while pinocembrin showed optimal binding with Japanese Encephalitis protein (−10.6 kcal/mol). ADMET predictions indicated a low carcinogenic risk for pinocembrin and naringenin, highlighting their potential safety and efficacy.</div></div><div><h3>Conclusions</h3><div>The seven identified flavonoids in <em>Crescentia cujete</em> exhibit promising antiviral properties, with superior docking scores and favourable ADMET profiles compared to certain commercial drugs. These flavonoids showed notable interactions with key viral proteins, with naringenin being the most active against the dengue and two COVID proteins, luteolin against hepatitis C and influenza A proteins, and pinocembrin against the Japanese encephalitis protein, suggesting these compounds as candidates for multitarget antiviral drug development.</div></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":"49 ","pages":"Article 100983"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In Silico Analysis of Flavonoids From Crescentia cujete L. for Possible Antiviral Applications\",\"authors\":\"Alecsanndra L. Gonzales , Cheng-Yang Hsieh , Ureah Thea A. Sevilla , Po-Wei Tsai\",\"doi\":\"10.1016/j.hermed.2024.100983\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Viruses, including the novel coronavirus responsible for the COVID-19 pandemic, continuously infect humans, causing illnesses of varying severity. Despite this, only a number of medicines were developed to counter some of these viruses and only preventive measures are being taken globally for some. This study explores the antiviral potential of flavonoids from <em>Crescentia cujete</em>.</div></div><div><h3>Methods</h3><div>Molecular docking was performed on seven flavonoid compounds isolated from <em>Crescentia cujete</em>, targeting viral proteins associated with COVID-19 (Omicron and Delta variants), dengue, hepatitis C, Japanese encephalitis, and influenza A. The binding affinities of these compounds were calculated to determine the most effective antiviral interactions.</div></div><div><h3>Results</h3><div>Docking simulations and absorption, distribution, metabolism, excretion, toxicity (ADMET) analyses identified naringenin as exhibiting the highest binding affinities against dengue (−10.44 kcal/mol) and COVID-19 (−9.24 and −10.31 kcal/mol) Omicron and Delta variants. Luteolin demonstrated strong activity against Hepatitis C (−10.26 kcal/mol) and Influenza A (−8.4 kcal/mol), while pinocembrin showed optimal binding with Japanese Encephalitis protein (−10.6 kcal/mol). ADMET predictions indicated a low carcinogenic risk for pinocembrin and naringenin, highlighting their potential safety and efficacy.</div></div><div><h3>Conclusions</h3><div>The seven identified flavonoids in <em>Crescentia cujete</em> exhibit promising antiviral properties, with superior docking scores and favourable ADMET profiles compared to certain commercial drugs. These flavonoids showed notable interactions with key viral proteins, with naringenin being the most active against the dengue and two COVID proteins, luteolin against hepatitis C and influenza A proteins, and pinocembrin against the Japanese encephalitis protein, suggesting these compounds as candidates for multitarget antiviral drug development.</div></div>\",\"PeriodicalId\":56077,\"journal\":{\"name\":\"Journal of Herbal Medicine\",\"volume\":\"49 \",\"pages\":\"Article 100983\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Herbal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2210803324001404\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Herbal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210803324001404","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
In Silico Analysis of Flavonoids From Crescentia cujete L. for Possible Antiviral Applications
Introduction
Viruses, including the novel coronavirus responsible for the COVID-19 pandemic, continuously infect humans, causing illnesses of varying severity. Despite this, only a number of medicines were developed to counter some of these viruses and only preventive measures are being taken globally for some. This study explores the antiviral potential of flavonoids from Crescentia cujete.
Methods
Molecular docking was performed on seven flavonoid compounds isolated from Crescentia cujete, targeting viral proteins associated with COVID-19 (Omicron and Delta variants), dengue, hepatitis C, Japanese encephalitis, and influenza A. The binding affinities of these compounds were calculated to determine the most effective antiviral interactions.
Results
Docking simulations and absorption, distribution, metabolism, excretion, toxicity (ADMET) analyses identified naringenin as exhibiting the highest binding affinities against dengue (−10.44 kcal/mol) and COVID-19 (−9.24 and −10.31 kcal/mol) Omicron and Delta variants. Luteolin demonstrated strong activity against Hepatitis C (−10.26 kcal/mol) and Influenza A (−8.4 kcal/mol), while pinocembrin showed optimal binding with Japanese Encephalitis protein (−10.6 kcal/mol). ADMET predictions indicated a low carcinogenic risk for pinocembrin and naringenin, highlighting their potential safety and efficacy.
Conclusions
The seven identified flavonoids in Crescentia cujete exhibit promising antiviral properties, with superior docking scores and favourable ADMET profiles compared to certain commercial drugs. These flavonoids showed notable interactions with key viral proteins, with naringenin being the most active against the dengue and two COVID proteins, luteolin against hepatitis C and influenza A proteins, and pinocembrin against the Japanese encephalitis protein, suggesting these compounds as candidates for multitarget antiviral drug development.
期刊介绍:
The Journal of Herbal Medicine, the official journal of the National Institute of Medical Herbalists, is a peer reviewed journal which aims to serve its readers as an authoritative resource on the profession and practice of herbal medicine. The content areas of the journal reflect the interests of Medical Herbalists and other health professionals interested in the clinical and professional application of botanical medicines. The objective is to strengthen the research and educational base of herbal medicine with research papers in the form of case studies, original research articles and reviews, monographs, clinical trials and relevant in vitro studies. It also publishes policy statements, opinion pieces, book reviews, conference proceedings and profession related information such as pharmacovigilance reports providing an information source for not only the Herbal Practitioner but any Health professional with an interest in phytotherapy.